References
- Barnett A. H., Leslie R. D. G., Pyke D. A. Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics. Br. Med. J. 1981; i: 522
- Barnett A. H., Leslie R. D. G., Pyke D. A. Chlorpropamide-alcohol flushing and large-vessel disease in non-insulin-dependent diabetes. Br. Med. J. 1980; i: 261
- Bertram F., Bendfeldt E., Otto H. Indikationen und Erfolge der peroralen Behandlung des Diabetes mellitus mit einem Sulfonylharn-stoffderivat. Dtsch. Med. Wschr. 1956; 81: 274
- De Silva N. E., Tunbridge W. M. G., Alberti K. G. M. M. Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-dependent diabetes. Lancet 1981; i: 128
- Horrobin D. F., Manku M. S. Chlorpropamide/alcohol flushing and prostaglandins. Lancet 1980; i: 935
- Jerntorp P., Almér L.-O. Chlorpropamide-alcohol flushing in relation to macro-angiopathy and peripheral neuropathy in non-insulin dependent diabetes. Acta med. Scand. 1981; 32(Suppl. 656)
- Jerntorp P., Almér L.-O., Melander A. Is the blood chlorpropamide critical in chlorpropamide alcohol flush?. Lancet 1981; i: 165
- Jerntorp P., Almér L.-O., Melander A. Chlorpropamide-induced inhibition of alcohol metabolism, the cause of CPAF. Diabetologia 1981; 21: 287
- Jerntorp P., Öhlin H., Bergström B., Almér L.-O. Elevation of plasma acetaldehyde—the first step in CPAF?. Diabetologia 1980; 19: 286
- Jerntorp P., Öhlin H., Bergström B., Almér L.-O. Increase in plasma acetaldehyde; an objective indicator of the chlorpropamide alcohol flush. Diabetes 1981; 30: 788
- Karamanos B., Christacopoulos P., Kardoyannis Th., Tountas Ch., Komninos Z. Chlorpropamide-alcohol flushing (CPAF). Evaluation of criteria. Prevalence. Relation to metabolic parameters. Diabetologia 1981; 21: 289
- Köbberling J., Bengsch N., Bruggeboes B., Schwarck H., Tillil H., Weber M. The chlorpropamide alcohol flush—lack of specificity for familial non-insulin dependent diabetes. Diabetologia 1980; 19: 359
- Leslie R. D. G., Barnett A. H., Pyke D. A. Diabetic retinopathy and chlorpropamide alcohol flushing. Lancet 1979; i: 997
- Leslie R. D. G., Pyke D. A. Chlorpropamide-alcohol flushing: a dominantly inherited trait associated with diabetes. Br. Med J. 1978; ii: 1519
- Leslie R. D. G., Pyke D. A., Stubbs W. A. Sensitivity to enkephalin as a cause of non-insulin-dependent diabetes. Lancet 1979; i: 341
- Lightman S. L., Summers M. C. Alterations in the activities of endogenous opiates by a metabolite of alcohol. J. Endocrin. 1980; 87: 38
- Podgainy H., Bressler R. Biochemical basis of the sulfonylurea-induced Antabuse syndrome. Diabetes 1968; 17: 679
- Radder J. K., Box M. C. J. G., Lemkes H. H. P. J. Facial skin temperature and the chlorpropamide/alcohol flush in diabetics. Lancet 1980; ii: 1037
- Squadrito G., Cucinottta D., Mileto A., Intrieri F. Chlorpropamide alcohol flushing (CPAF) and diabetes mellitus in a Southern Italian population. Diabetologia 1981; 21: 82
- Stowell A. R. An improved method for the determination of acetaldehyde in human blood with minimal ethanol interference. Clin. chim. Acta 1979; 98: 201
- Strakosch C. R., Jefferys D. B., Keen H. Blockade of chlorpropamide alcohol flush by aspirin. Lancet 1980; i: 394